Treating Type 2 Diabetes with ASCVD
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Treating Type 2 Diabetes with ASCVD
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
A 60-year-old male with documented ASCVD, obesity with BMI of 34, and type 2 diabetes presents for care. The patient reports he's currently feeling well without episodes of hypoglycemia. Current laboratory assessment includes the following. A1C is 8.6 % and his estimated GFR is at 62. Current medications include metformin at optimized dose and a sulfonyl urea.
Which of the following represents the nurse practitioner's next best action?
A. continue on current therapy and arrange for a three month follow up
B. discontinue the metformin and add a DPP4 inhibitor
C. add a GLP-1 inhibitor and discontinue the sulfonyl urea
D. add basal insulin and titrate to fasting glycemic goals
---
YouTube: https://www.youtube.com/watch?v=8ybH1qcskq8&list=PLf0PFEPBXfq592b5zCthlxSNIEM-H-EtD&index=124
Visit fhea.com to learn more!